- TEVA TO buy local unit for Rs 400 cr
The world’s largest generic drug manufacturer Teva may be close to acquiring domestic company Saraca Labs’ manufacturing plant in Hyderabad...
29 Jun, 2007, 01.39 AM IST
- Mylan Labs may use Indian platform for global pharma play
With the acquisition of Merck KGaA’s generic business by Mylan Laboratories, India is set to become a major manufacturing hub for the US dr...
14 May, 2007, 12.27 AM IST
- Cipla, PEs team up for Merck's biz
Ranbaxy Lab, Teva Corp, Actavis and Mylan are among the cos short listed in the first round.
16 Mar, 2007, 02.08 AM IST
- Merck Generics valuation to be hit as Duoneb patent ends
Merck Generics' lucrative US subsidiary Dey, a specialty pharmaceutical company focused on the development of new drug delivery systems for...
02 Mar, 2007, 12.43 AM IST
- Cos exit generics for core focus
As international generics drug markets reel under increasing pricing pressure and ever-rising competition, big pharma companies are selling...
10 Jan, 2007, 12.39 AM IST
- Merck buy may give Ranbaxy access to US, Europe markets
Ranbaxy Labs has joined the race with global pharma companies such as Teva, Novartis and Sanofi-Aventis for acquiring the global generic dr...
09 Jan, 2007, 02.14 AM IST
- Ranbaxy may pop Merck pill
Ranbaxy Labs has entered the race for acquiring the global generic drug business of Merck KGaA.
09 Jan, 2007, 01.56 AM IST
- Safe & steady strategy gives Cipla lead over Ranbaxy
Some years ago, investors were hooked to Ranbaxy Labs’ growth story and the many earnings triggers that lay ahead.
30 Oct, 2006, 01.54 AM IST